Perel, a renowned psychotherapist, doesn’t really think society can — or should — fall in love with a machine.
For decades, building software has been a labor-intensive process—writing thousands of lines of code, coordinating across ...
Leaders with CureDuchenne say approvals are expected this year for several new treatments for Duchenne MD, making it "an ...
On Friday, OpenAI engineer Michael Bolin published a detailed technical breakdown of how the company’s Codex CLI coding agent ...
Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results